🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Gisela Canedo-Marroquín

Pontificia Universidad Católica de Chile

ORCID: 0000-0001-8629-5847

Also affiliated with Universidad de Los Andes, Chile, Millennium Institute on Immunology and Immunotherapy

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial”.

Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial

medRxiv(2021)10.1101/2021.03.31.21254494

N/A

4.6DataRank · unranked

59 citations

Katia Abarca, Pablo A. González, Nicolás M. S. Gálvez, Jorge A. Soto, Luisa F. Duarte +41 more

Current Insights in the Development of Efficacious Vaccines Against RSV

Frontiers in Immunology(2020)10.3389/fimmu.2020.01507

N/A

0DataRank · unranked

43 citations

Laura Stephens, Kody Waldstein, Gisela Canedo-Marroquín, Steven M. Varga, Alexis M. Kalergis +1 more

Safety and Immunogenicity of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Subgroup of Healthy Adults in Chile

Clinical Infectious Diseases(2021)10.1093/cid/ciab823

N/A

0DataRank · unranked

109 citations

Katia Abarca, Pablo A. González, Nicolás M. S. Gálvez, Jorge A. Soto, Luisa F. Duarte +41 more